Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis

Table 3 Illness perceptions in patients with high, medium and low medication adherence

Brief illness perception questionnaire items	All patients(n = 100)	Medication adherence ranking			P value
		High	Medium	Low
		(n = 42)	(n = 37)	(n = 21)
Consequences	6.0 ± 3.1	6.1 ± 3.0	6.0 ± 3.1	5.7 ± 3.2	0.846
How much does your liver disease affect your life?
0 = No affect; 10 = Severely affects my life
Timeline	10.0 (0-10)	10 (3-10)	10 (0-10)	10 (3-10)	0.962
How long do you think your liver disease will continue?
0 = Very short time; 10 = Forever
Personal Control	4.8 ± 3.0	4.6 ± 3.2	4.8 ± 2.9	5.0 ± 2.8	0.893
How much control do you feel you have over your liver disease?
0 = Absolutely no control; 10 = Extreme amount of control
Treatment Control	8.0 (0-10)	8 (2-10)	10 (4-10)	7 (0-10)	0.003
How much do you think your treatment can help your liver disease?
0 = Not at all; 10 = Extremely helpful
Identity	5.5 ± 3.0	5.6 ± 3.0	5.5 ± 3.0	5.2 ± 2.9	0.905
How much do you experience symptoms from your liver disease?
0 = No symptoms; 10 = Many severe symptoms
Concern	8.0 (0-10)	8 (0-10)	9 (0-10)	8 (0-10)	0.416
How concerned are you about your liver disease?
0 = Not at all; 10 = Extremely concerned
Coherence	8.0 (0-10)	8 (3-10)	8 (0-10)	7 (2-9)	0.014
How well do you feel you understand your liver disease?
0 = Don’t understand at all; 10 = Understand very clearly
Emotional Representation	4.9 ± 3.4	4.7 ± 3.2	5.1 ± 3.9	4.7 ± 3.1	0.874
How much does your liver disease affect you emotionally?
0 = Not at all; 10 = Extremely affected emotionally

Normally distributed data presented as mean ± SD and analysed using one-way ANOVA. Non-normally distributed data presented as median group score and (range) and analysed using the Kruskal-Wallis H Test.